Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 473

1.

A Festschrift in Honor of Edward M. Messing, MD, FACS.

Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, Lerner S, Palapattu G, Wilding G, Droller M, Trump D.

Bladder Cancer. 2018 Oct 3;4(Suppl 1):S1-S43. doi: 10.3233/BLC-189037. No abstract available.

PMID:
30443561
2.

Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.

Chen GL, Hahn T, Wilding GE, Groman A, Hutson A, Zhang Y, Khan U, Liu H, Ross M, Bambach B, Higman M, Neppalli V, Sait S, Block AW, Wallace PK, Singh AK, McCarthy PL.

Biol Blood Marrow Transplant. 2018 Oct 6. pii: S1083-8791(18)30609-8. doi: 10.1016/j.bbmt.2018.09.042. [Epub ahead of print]

PMID:
30300731
3.

Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.

Merzianu M, Groman A, Hutson A, Cotta C, Brynes RK, Orazi A, Reddy V, Teruya-Feldstein J, Amre R, Balasubramanian M, Brandao G, Cherian S, Courville E, Czuchlewski D, Fan G, Grier D, Hoehn D, Inamdar KV, Juskevicius R, Kaur P, Lazarchick J, Lewis MR, Miles RR, Myers JB, Nasr MR, Qureishi HN, Olteanu H, Robu VG, Salaru G, Vajpayee N, Vos J, Zhang L, Zhang S, Aye L, Brega E, Coad JE, Grantham J, Ivelja S, McKenna R, Sultan K, Wilding G, Hutchison R, Peterson L, Cheney RT.

Am J Clin Pathol. 2018 Oct 1;150(5):393-405. doi: 10.1093/ajcp/aqy066.

PMID:
30052721
4.

Validation of fitness tracker for sleep measures in women with asthma.

Castner J, Mammen MJ, Jungquist CR, Licata O, Pender JJ, Wilding GE, Sethi S.

J Asthma. 2018 Aug 24:1-12. doi: 10.1080/02770903.2018.1490753. [Epub ahead of print]

PMID:
29972657
5.

Salivary metals, age, and gender correlate with cultivable oral Candida carriage levels.

Norris HL, Friedman J, Chen Z, Puri S, Wilding G, Edgerton M.

J Oral Microbiol. 2018 Mar 13;10(1):1447216. doi: 10.1080/20002297.2018.1447216. eCollection 2018.

6.

Small bowel fed response as measured by wireless motility capsule: Comparative analysis in healthy, gastroparetic, and constipated subjects.

Surjanhata B, Brun R, Wilding G, Semler J, Kuo B.

Neurogastroenterol Motil. 2018 May;30(5):e13268. doi: 10.1111/nmo.13268. Epub 2017 Dec 18.

PMID:
29250864
7.

A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma.

Torka P, Patel P, Tan W, Wilding G, Bhat SA, Czuczman MS, Lee KP, Deeb G, Neppalli V, Mavis C, Wallace P, Hernandez-Ilizaliturri FJ.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e51-e60. doi: 10.1016/j.clml.2017.09.003. Epub 2017 Nov 6.

PMID:
29233743
8.

Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A.

Perez AC, Johnson A, Chen Z, Wilding GE, Malkowski MG, Murphy TF.

Infect Immun. 2018 Feb 20;86(3). pii: e00652-17. doi: 10.1128/IAI.00652-17. Print 2018 Mar.

9.

Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial.

Wong YN, Manola J, Hudes GR, Roth BJ, Moul JW, Barsevick AM, Scher RM, Volk MJ, Vaughn DJ, Williams SD, Fisch MJ, Cella D, Carducci MA, Wilding G.

Clin Genitourin Cancer. 2018 Apr;16(2):e315-e322. doi: 10.1016/j.clgc.2017.10.001. Epub 2017 Oct 16.

PMID:
29173976
10.

Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.

Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Yang Y, Wilding GE, Morse GD.

Ther Drug Monit. 2017 Dec;39(6):596-603. doi: 10.1097/FTD.0000000000000443.

PMID:
29135907
11.

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

Armstrong AJ, Antonarakis ES, Taplin ME, Kelly WK, Beltran H, Fizazi K, Dahut WL, Shore N, Slovin S, George D, Carducci MA, Corn P, Danila D, Dreicer R, Heath E, Rathkopf D, Liu G, Nanus D, Stein M, Smith MR, Sternberg C, Wilding G, Nelson PS, Halabi S, Kantoff P, Clarke NW, Evans CP, Heidenreich A, Mottet N, Gleave M, Morris MJ, Scher HI.

Ann Oncol. 2018 Jan 1;29(1):23-25. doi: 10.1093/annonc/mdx648. No abstract available.

PMID:
29088323
12.

Immunoglobulin A Protease Variants Facilitate Intracellular Survival in Epithelial Cells By Nontypeable Haemophilus influenzae That Persist in the Human Respiratory Tract in Chronic Obstructive Pulmonary Disease.

Murphy TF, Kirkham C, Gallo MC, Yang Y, Wilding GE, Pettigrew MM.

J Infect Dis. 2017 Dec 5;216(10):1295-1302. doi: 10.1093/infdis/jix471.

PMID:
28968876
13.

A Cation-binding Surface Protein as a Vaccine Antigen to Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.

Murphy TF, Brauer AL, Johnson A, Wilding GE, Koszelak-Rosenblum M, Malkowski MG.

Clin Vaccine Immunol. 2017 Jun 28. pii: CVI.00130-17. doi: 10.1128/CVI.00130-17. [Epub ahead of print]

14.

Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center.

Engle JA, Traynor AM, Campbell TC, Wisinski KB, LoConte N, Liu G, Wilding G, Kolesar JM.

J Oncol Pharm Pract. 2018 Jul;24(5):348-353. doi: 10.1177/1078155217704989. Epub 2017 Apr 29.

PMID:
28457192
15.

Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.

Tang C, Sherman SI, Price M, Weng J, Davis SE, Hong DS, Yao JC, Buzdar A, Wilding G, Lee JJ.

Clin Cancer Res. 2017 Mar 15;23(6):1414-1421. doi: 10.1158/1078-0432.CCR-16-2439. Epub 2017 Mar 8.

16.

Reply by the Authors.

May PR, Hussein AA, Wilding G, Guru KA.

Urology. 2017 Mar;101:175. doi: 10.1016/j.urology.2016.12.005. Epub 2016 Dec 21. No abstract available.

PMID:
28013037
17.

Development and Validation of an Objective Scoring Tool for Robot-Assisted Radical Prostatectomy: Prostatectomy Assessment and Competency Evaluation.

Hussein AA, Ghani KR, Peabody J, Sarle R, Abaza R, Eun D, Hu J, Fumo M, Lane B, Montgomery JS, Hinata N, Rooney D, Comstock B, Chan HK, Mane SS, Mohler JL, Wilding G, Miller D, Guru KA; Michigan Urological Surgery Improvement Collaborative and Applied Technology Laboratory for Advanced Surgery Program.

J Urol. 2017 May;197(5):1237-1244. doi: 10.1016/j.juro.2016.11.100. Epub 2016 Nov 29.

PMID:
27913152
18.

Vitamin D supplementation affects the IGF system in men after acute exercise.

Darr RL, Savage KJ, Baker M, Wilding GE, Raswalsky A, Rideout T, Browne RW, Horvath PJ.

Growth Horm IGF Res. 2016 Oct - Dec;30-31:45-51. doi: 10.1016/j.ghir.2016.11.002. Epub 2016 Nov 5.

PMID:
27863277
19.

Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-year Analysis.

Hussein AA, Dibaj S, Hinata N, Field E, O'leary K, Kuvshinoff B, Mohler JL, Wilding G, Guru KA.

Urology. 2016 Nov;97:124-129. doi: 10.1016/j.urology.2016.06.063. Epub 2016 Aug 1.

PMID:
27491964
20.

Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours.

Mahalingam D, Wilding G, Denmeade S, Sarantopoulas J, Cosgrove D, Cetnar J, Azad N, Bruce J, Kurman M, Allgood VE, Carducci M.

Br J Cancer. 2016 Apr 26;114(9):986-94. doi: 10.1038/bjc.2016.72.

21.

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.

Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS.

Lancet. 2016 May 14;387(10032):2008-16. doi: 10.1016/S0140-6736(16)00559-6. Epub 2016 Mar 9. Erratum in: Lancet. 2016 May 14;387(10032):1998.

22.

A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin E 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer.

Kyriakopoulos CE, Heath EI, Eickhoff JC, Kolesar J, Yayehyirad M, Moll T, Wilding G, Liu G.

Invest New Drugs. 2016 Apr;34(2):225-30. doi: 10.1007/s10637-016-0334-y. Epub 2016 Feb 29.

PMID:
26924129
23.

Measures of biomarker dependence using a copula-based multivariate epsilon-skew-normal family of distributions.

Hutson AD, Wilding GE, Mashtare TL, Vexler A.

J Appl Stat. 2015;42(12):2734-2753. Epub 2015 May 26.

24.

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, Antonarakis ES, Beer TM, Carducci MA, Chi KN, Corn PG, de Bono JS, Dreicer R, George DJ, Heath EI, Hussain M, Kelly WK, Liu G, Logothetis C, Nanus D, Stein MN, Rathkopf DE, Slovin SF, Ryan CJ, Sartor O, Small EJ, Smith MR, Sternberg CN, Taplin ME, Wilding G, Nelson PS, Schwartz LH, Halabi S, Kantoff PW, Armstrong AJ; Prostate Cancer Clinical Trials Working Group 3.

J Clin Oncol. 2016 Apr 20;34(12):1402-18. doi: 10.1200/JCO.2015.64.2702. Epub 2016 Feb 22.

25.

Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma.

Rohrbach DJ, Rigual N, Arshad H, Tracy EC, Cooper MT, Shafirstein G, Wilding G, Merzianu M, Baumann H, Henderson BW, Sunar U.

J Biomed Opt. 2016 Jan;21(1):18002. doi: 10.1117/1.JBO.21.1.018002. No abstract available.

26.

A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer.

Deming DA, Cavalcante LL, Lubner SJ, Mulkerin DL, LoConte NK, Eickhoff JC, Kolesar JM, Fioravanti S, Greten TF, Compton K, Doyle AG, Wilding G, Duffy A, Liu G.

Invest New Drugs. 2016 Apr;34(2):168-75. doi: 10.1007/s10637-015-0314-7. Epub 2015 Dec 14.

27.
28.

Comparison of Intelligibility Measures for Adults With Parkinson's Disease, Adults With Multiple Sclerosis, and Healthy Controls.

Stipancic KL, Tjaden K, Wilding G.

J Speech Lang Hear Res. 2016 Apr 1;59(2):230-8. doi: 10.1044/2015_JSLHR-S-15-0271.

29.

Reoperations following Robot-Assisted Radical Cystectomy: A Decade of Experience.

Hussein AA, Hashmi Z, Dibaj S, Altartir T, Fiorica T, Wing J, Durrani M, Binkowski J, Boateng L, Wilding G, Guru KA.

J Urol. 2016 May;195(5):1368-1376. doi: 10.1016/j.juro.2015.10.171. Epub 2015 Nov 6.

PMID:
26551296
30.

Optimal adaptive two-stage designs for early phase II clinical trials.

Shan G, Wilding GE, Hutson AD, Gerstenberger S.

Stat Med. 2016 Apr 15;35(8):1257-66. doi: 10.1002/sim.6794. Epub 2015 Nov 3.

31.

Blunting of Colon Contractions in Diabetics with Gastroparesis Quantified by Wireless Motility Capsule Methods.

Coleski R, Wilding GE, Semler JR, Hasler WL.

PLoS One. 2015 Oct 28;10(10):e0141183. doi: 10.1371/journal.pone.0141183. eCollection 2015.

32.

Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.

Chen Y, Rini BI, Motzer RJ, Dutcher JP, Rixe O, Wilding G, Stadler WM, Tarazi J, Garrett M, Pithavala YK.

Target Oncol. 2016 Apr;11(2):229-34. doi: 10.1007/s11523-015-0389-2.

33.

Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.

Venuto RC, Meaney CJ, Chang S, Leca N, Consiglio JD, Wilding GE, Brazeau D, Gundroo A, Nainani N, Morse SE, Cooper LM, Tornatore KM.

Medicine (Baltimore). 2015 Sep;94(37):e1315. doi: 10.1097/MD.0000000000001315.

34.

Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800).

Carducci MA, Manola J, Nair SG, Liu G, Rousey S, Dutcher JP, Wilding G.

Clin Genitourin Cancer. 2015 Dec;13(6):531-539.e1. doi: 10.1016/j.clgc.2015.07.002. Epub 2015 Jul 17.

35.

Leinamycin E1 acting as an anticancer prodrug activated by reactive oxygen species.

Huang SX, Yun BS, Ma M, Basu HS, Church DR, Ingenhorst G, Huang Y, Yang D, Lohman JR, Tang GL, Ju J, Liu T, Wilding G, Shen B.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8278-83. doi: 10.1073/pnas.1506761112. Epub 2015 Jun 8.

36.

Determination of genotypes using a fully automated molecular detection system.

Spizz G, Chen Z, Li P, McGuire IC, Klimkiewicz P, Zysling D, Yasmin R, Hungerford W, Thomas B, Wilding G, Mouchka G, Young L, Zhou P, Montagna RA.

Arch Pathol Lab Med. 2015 Jun;139(6):805-11. doi: 10.5858/arpa.2014-0059-OA.

PMID:
26030250
37.

Potential cytochrome P-450 drug-drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trials.

Wisinski KB, Cantu CA, Eickhoff J, Osterby K, Tevaarwerk AJ, Heideman J, Liu G, Wilding G, Johnston S, Kolesar JM.

Am J Health Syst Pharm. 2015 Jun 1;72(11):958-65. doi: 10.2146/ajhp140591.

38.

Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.

Raza SJ, Wilson T, Peabody JO, Wiklund P, Scherr DS, Al-Daghmin A, Dibaj S, Khan MS, Dasgupta P, Mottrie A, Menon M, Yuh B, Richstone L, Saar M, Stoeckle M, Hosseini A, Kaouk J, Mohler JL, Rha KH, Wilding G, Guru KA.

Eur Urol. 2015 Oct;68(4):721-8. doi: 10.1016/j.eururo.2015.04.021. Epub 2015 May 16.

PMID:
25985883
39.

Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805.

Haas NB, Manola J, Ky B, Flaherty KT, Uzzo RG, Kane CJ, Jewett M, Wood L, Wood CG, Atkins MB, Dutcher JJ, Wilding G, DiPaola RS.

Clin Cancer Res. 2015 Sep 15;21(18):4048-54. doi: 10.1158/1078-0432.CCR-15-0215. Epub 2015 May 12.

40.

Expression of spermidine/spermine N(1) -acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis.

Huang W, Eickhoff JC, Mehraein-Ghomi F, Church DR, Wilding G, Basu HS.

Prostate. 2015 Aug 1;75(11):1150-9. doi: 10.1002/pros.22996. Epub 2015 Apr 20.

41.

Likelihood-based inferences about the mean area under a longitudinal curve in the presence of observations subject to limits of detection.

Chandrasekhar R, Shi Y, Hutson AD, Wilding GE.

Pharm Stat. 2015 May-Jun;14(3):252-61. doi: 10.1002/pst.1681. Epub 2015 Apr 1.

PMID:
25832442
42.

A Novel Approach to Testing for Average Bioequivalence Based on Modeling the Within-Period Dependence Structure.

Chandrasekhar R, Shi Y, Hutson AD, Wilding GE.

J Biopharm Stat. 2015;25(6):1320-38. doi: 10.1080/10543406.2014.1000677. Epub 2015 Feb 11.

PMID:
25671781
43.

Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide-a for early-stage cancer of the larynx: Phase Ib study.

Shafirstein G, Rigual NR, Arshad H, Cooper MT, Bellnier DA, Wilding G, Tan W, Merzianu M, Henderson BW.

Head Neck. 2016 Apr;38 Suppl 1:E377-83. doi: 10.1002/hed.24003. Epub 2015 Jun 29.

44.

A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802.

DiPaola RS, Chen YH, Bubley GJ, Stein MN, Hahn NM, Carducci MA, Lattime EC, Gulley JL, Arlen PM, Butterfield LH, Wilding G.

Eur Urol. 2015 Sep;68(3):365-71. doi: 10.1016/j.eururo.2014.12.010. Epub 2014 Dec 18.

45.

Surgical competency for urethrovesical anastomosis during robot-assisted radical prostatectomy: development and validation of the robotic anastomosis competency evaluation.

Raza SJ, Field E, Jay C, Eun D, Fumo M, Hu JC, Lee D, Mehboob Z, Nyquist J, Peabody JO, Sarle R, Stricker H, Yang Z, Wilding G, Mohler JL, Guru KA.

Urology. 2015 Jan;85(1):27-32. doi: 10.1016/j.urology.2014.09.017.

PMID:
25530362
46.

Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients.

Tornatore KM, Meaney CJ, Wilding GE, Chang SS, Gundroo A, Cooper LM, Gray V, Shin K, Fetterly GJ, Prey J, Clark K, Venuto RC.

Clin Pharmacokinet. 2015 Apr;54(4):423-34. doi: 10.1007/s40262-014-0213-7.

47.

A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer.

Zeitouni NC, Sunar U, Rohrbach DJ, Paquette AD, Bellnier DA, Shi Y, Wilding G, Foster TH, Henderson BW.

Dermatol Surg. 2014 Dec;40(12):1390-4. doi: 10.1097/DSS.0000000000000183.

48.

Healthy Lifestyle Behaviors of Breast Cancer Survivors.

DeNysschen C, Brown JK, Baker M, Wilding G, Tetewsky S, Cho MH, Dodd MJ.

Clin Nurs Res. 2015 Oct;24(5):504-25. doi: 10.1177/1054773814553298. Epub 2014 Oct 13.

PMID:
25349070
49.

A comparison of exact tests for trend with binary endpoints using Bartholomew's statistic.

Consiglio JD, Shan G, Wilding GE.

Int J Biostat. 2014;10(2):221-30. doi: 10.1515/ijb-2014-0013.

PMID:
25324456
50.

International Robotic Radical Cystectomy Consortium: A way forward.

Raza SJ, Field E, Kibel AS, Mottrie A, Weizer AZ, Wagner A, Hemal AK, Scherr DS, Schanne F, Gaboardi F, Wu G, Peabody JO, Koauk J, Redorta JP, Pattaras JG, Rha KH, Richstone L, Balbay MD, Menon M, Hayn M, Stoeckle M, Wiklund P, Dasgupta P, Pruthi R, Ghavamian R, Khan S, Siemer S, Maatman T, Wilson T, Poulakis V, Wilding G, Guru KA.

Indian J Urol. 2014 Jul;30(3):314-7. doi: 10.4103/0970-1591.134253.

Supplemental Content

Loading ...
Support Center